Navigation Links
Photonic Products Group, Inc. ("PPGI") Releases FY 2010 Financial Results

NORTHVALE, N.J., April 4, 2011 /PRNewswire/ -- Photonic Products Group, Inc. (OTC Bulletin Board: PHPG) has released its consolidated financial results for the year ended December 31, 2010.

The Company ended the year with fourth quarter sales of $3.6 million, an increase of 22% from $2.95 million in the corresponding quarter of 2009.  Sales for the year were $11.05 million, unchanged from 2009.

Bookings for 2010 were $12.3 million compared to $9.5 million, or 29% higher than 2009.  The company booked $3.4 million in new orders in the fourth quarter of 2010, up from $3.1 million in the in the fourth quarter of 2009.   Year-end backlog was $5.4 million versus $4.4 million at the end of 2009, or a 23% improvement.  

Net income, applicable to common shareholders was $471,000 for the fourth quarter of 2010,  versus a net loss of ($26,000), for the fourth quarter 2009.  Fourth quarter earnings per share were $0.04 basic and diluted versus $0.00 in 2009.

For the year ended December 31, 2010, the Company's net loss was ($734,000).  In 2009 the Company reported a net loss of ($2.8) million which included a non-cash goodwill impairment charge of $1.6 million.  Excluding the impairment charge last year, net loss was ($1.2) million.  For 2010, basic and diluted net loss per share was ($0.06)  versus a net loss of ($0.25) per share in 2009.  

As a result of stronger fourth quarter sales, gross profit increased by 63% to $1.22 million or 33.9% of sales, up from $747,000 or 25.3%, of sales in the fourth quarter of 2009.  For 2010, gross profit improved to $2.5 million or 22.7% of sales versus $2.2 million or 19.5% of sales, in 2009.

EBITDA(1) for 2010 was $514,000 compared to EBITDA of ($1.5) million in 2009. Excluding the $1.6 million goodwill impairment charge, which the Company recorded in the third quarter of 2009, adjusted EBITDA(2) for 2009 was $10,000.  

During the year, management maintained tight control over discretionary expenses, selectively invested in capital expenditures and focused on cash conservation. Net cash flow from operating activities in 2010 was $576,000, down from $815,000 in 2009.  Cash flow in 2010 was negatively impacted by fourth quarter increases in accounts receivable balances, reflecting higher sales in the period, offset by increases in accounts payable and customer advance balances at the end of 2010. Although the Company incurred losses in 2010, PPGI ended the year with a stronger cash position, of $4.4 million, up $296,000, versus $4.1 million, at the end of 2009.

Joe Rutherford, President and CEO of PPGI stated,   "Although we have continued to deal with the lingering effects of a depressed economy in the markets we serve, which has negatively affected our performance for the past two years, our 2010 results are encouraging.  Our 2010 fourth quarter results were particularly positive as sales were the highest since the fourth quarter of 2008.  In addition, bookings of $3.4 million in our fourth quarter, followed strong third quarter bookings of $4.6 million.   This represents the two highest bookings quarters since the first quarter of 2008.  The optimism I have previously expressed has been borne out by our 2010 results. I feel confident that our focus on internal process improvement, adding engineering resources, new product development, and increased customer focus domestically and internationally, as well as selective and strategic investment in capital equipment will position us for success as our markets continue to rebound and demand for our products grows."

(1), (2)   Note Regarding Use of Certain Non-GAAP Financial Measures:

The Company defines EBITDA(1) as (loss) earnings before non-cash, stock-based compensation, net interest, income taxes, depreciation, and amortization.  Adjusted EBITDA(2) is calculated by excluding the goodwill impairment charge from the EBITDA results.  EBITDA and adjusted EBITDA are presented herein because we consider these numbers an important measure of the Company's ability to internally fund capital expenditures and service debt.  EBITDA and adjusted EBITDA should not be considered an alternative to cash flow as an indicator of the Company's financial performance, or liquidity.  The reader is referred to the Supplemental Financial Data set forth below for a reconciliation of net (loss) income to EBITDA.  

The reconciliation follows:Years ended December 31,Reconciliation of  EBITDA and adjusted EBITDA to Net Loss20102009(In thousands)Net (loss), as reported$


(2,800)Interest expense, net138131Depreciation and amortization9421,008Non-cash, stock-based compensation168113EBITDA$


(1,548)Goodwill impairment charge—1,558Adjusted EBITDA$


10Founded in 1973, Photonic Products Group, Inc. develops, manufactures, and markets products and services for use in a diverse Photonics industry via three brand names INRAD, Laser Optics ("LOI") and MRC. INRAD specializes in crystal-based optical components, optical devices, laser accessories and instruments.  LOI specializes in custom optical components, assemblies, and optical coatings. MRC specializes in custom diamond turned metal and crystalline optics, and opto-mechanical and electro-optical assemblies. PPGI's customers include leading corporations in the Defense, Aerospace, Laser System manufacturers, Process Control system manufacturers   in the Photonics Industry marketplace.   PPGI products are used directly by researchers within U.S. Government supported laboratories, National/International Research Laboratories and Universities world-wide.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this press release that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These statements may be identified by their use of forward-looking terminology such as "believes", "expects", "should", "will", "plan", "anticipate", "probably", "targeting" or similar words.  Such forward-looking statements, such as our expectation for revenues, new orders, and improved results involve risks and uncertainties that could cause actual results to differ materially from those projected. Risks and uncertainties that could cause actual results to differ materially from such forward looking statements are, but are not limited to, uncertainties in market demand for the company's products or the products of its customers, future actions by competitors, inability to deliver product on time, inability to develop new business, inability to retain key employees or hire new employees, and other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission including our Annual Report on Form 10-K for the year ended December 31, 2010. The forward looking statements made in this news release are made as of the date hereof and Photonic Products Group, Inc. does not assume any obligation to update publicly any forward looking statement.

PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETSDecember 31,20102009AssetsCurrent assets:Cash and cash equivalents$


4,069,310Accounts receivable (after allowance for doubtful accounts of $15,000 in 2010 and 2009)2,224,5921,927,672Inventories, net2,390,8762,265,973Other current assets119,243164,081Total Current Assets9,099,7568,427,036Plant and equipment:Plant and equipment at cost14,879,50814,604,728Less: Accumulated depreciation and amortization(12,876,163)(12,016,247)Total plant and equipment2,003,3452,588,481Precious Metals157,443157,443Deferred Income Taxes408,000408,000Goodwill311,572311,572Intangible Assets, net of accumulated amortization 594,452673,016Other Assets47,23545,192Total Assets$


12,610,740Liabilities and Shareholders' EquityCurrent Liabilities:Current portion of notes payable -other$


9,000Accounts payable and accrued liabilities836,190657,650Customer advances441,987346,429Total Current Liabilities1,287,1771,013,079Related Party Convertible Notes Payable2,500,0002,500,000Accrued Interest on Related Party Convertible Note Payable1,125,000975,000Notes Payable – Other, net of current portion335,874344,946Total Liabilities5,248,0514,833,025Commitments Shareholders' equity:Common stock: $.01 par value; 60,000,000 authorized shares 11,562,656 issued at December 31, 2010 and 11,443,347 issued at December 31, 2009115,626114,433Capital in excess of par value17,402,52817,073,871Accumulated deficit(10,129,452)(9,395,639)7,388,7027,792,665Less - Common stock in treasury, at cost (4,600 shares)(14,950)(14,950)Total Shareholders' Equity7,373,7527,777,715Total Liabilities and Shareholders' Equity$





16,301,209Cost and expensesCost of goods sold8,545,1538,896,53911,486,620Selling, general and administrative expense3,105,0633,278,1613,857,805Goodwill Impairment—1,558,074—11,650,21613,732,77415,344,425Operating (loss) income(596,038)(2,681,647)956,784Other income (expense)Interest expense, net(137,775)(130,387)(170,476)Gain on sale of plant and equipment—4,6719,113Gain on sale of precious metals—7,371—(137,775)(118,345)(161,363)(Loss) income before income taxes (733,813)(2,799,992)795,421Income tax benefit (provision) ——303,000Net (loss) income $



1,098,421Net (loss) income per share - basic$



0.10Net (loss) income per share - diluted$



0.08Weighted average shares outstanding - basic11,522,29711,331,25810,902,061Weighted average shares outstanding – diluted11,522,29711,331,25815,619,304PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWSYears Ended December 31,201020092008Cash flows from operating activities:Net (loss) income$



1,098,421Adjustments to reconcile net (loss) income to net cash provided by operating activities:Depreciation and amortization941,9411,008,3101,059,741Goodwill impairment charge—1,558,074—401K common stock contribution154,535179,068160,180Accrued interest on Related Party Convertible Note Payable150,000150,000150,000Deferred income taxes——(408,000)Gain on sale of plant and equipment—(4,671)(9,113)Gain on sale of precious metal—(7,371)—Stock-based compensation expense168,054112,95088,417Change in inventory reserve(154,326)94,628302,511Changes in operating assets and liabilities:Accounts receivable(296,920)882,930(628,743)Inventories29,423371,735(103,767)Other current assets 44,83824,003(24,019)Other assets(2,043)34,1077,865Accounts payable and accrued liabilities178,540(678,015)(731,301)Customer advances95,558(110,325)(413,796)Total adjustments1,309,6003,615,423(550,025)Net cash provided by operating activities575,787815,431548,396Cash flows from investing activities:Proceeds (purchase) of certificates of deposit—800,000(800,000)Purchase of plant and equipment(278,241)(210,563)(784,534)Purchase of precious metals—(53,538—Proceeds from disposal of plant and equipment—4,67110,000Proceeds from disposal of precious metals —16,317—Net cash (used in) provided by investing activities(278,241)556,887(1,574,534)Cash flows from financing activities:Net proceeds from issuance of common stock7,261161,5141,064,357Principal payments of notes payable-other(9,072)(136,609)(14,989)Principal payments of convertible promissory notes——(1,700,000)Principal payments of capital lease obligations——(47,088)Net cash (used in) provided by financing activities(1,811)24,905(697,720)Net increase (decrease) in cash and cash equivalents295,7351,397,223(1,723,859)Cash and cash equivalents at beginning of the year4,069,3102,672,0874,395,945Cash and cash equivalents at end of the year$



2,672,087Supplemental Disclosure of Cash Flow Information:Interest paid$



508,000Income taxes (refund) paid$



408,000PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIESQUARTERLY DATA (Unaudited)Year 2010FirstSecondThirdFourthNet sales$




3,603,060Gross profit540,494255,712494,6781,218,141Net income (loss)(274,469)(648,898)(281,755)471,309Net income (loss) per share - Basic (0.02)(0.06)(0.02)0.04Net income (loss) per share – Diluted (0.02)(0.06)(0.02)0.04Year 2009FirstSecondThirdFourthNet sales$




2,950,630Gross profit381,687419,098606,530747,273Net loss(314,409)(336,998)(2,122,330)(26,255)Net loss per share - Basic (0.03)(0.03)(0.19)(0.00)Net loss per share - Diluted (0.03)(0.03)(0.19)(0.00)Year 2008FirstSecondThirdFourthNet sales$




4,326,614Gross profit1,501,5931,219,2021,065,4241,028,370Net income491,200294,017169,120144,084Net income per share - Basic income per share - Diluted

SOURCE Photonic Products Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OTC Anti-Aging Products: Hype or Hope?
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
4. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
5. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
6. Positive Results Published Using AtriCure Minimally Invasive Products
7. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
8. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
9. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
Post Your Comments:
(Date:11/24/2015)... -- The hope of bearing a child ... cycles. After failure of over 15 IVF cycles, Mrs. ... hopes that she would be able to conceive ever. But finally optimism prevailed as she ... of over 15 IVF cycles. India ... one last attempt with Gaudium IVF Center in New ...
(Date:11/24/2015)...  Thanks to a donor with a personal connection ... Sister Diane Grassilli Center for Women,s Health now offers ... San Francisco . Fred Ruhland ... a gift of $617,320 that allowed the Center to ... and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography for ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... In an ongoing Clinical Study conducted by an independent ... UV Angel is evaluating the efficacy of its product and its disinfection protocol. This ... beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary ... individuals and groups responsible for advancing care for pulmonary hypertension (PH) patients and ... the public, will receive special recognition throughout 2016 as part of PHA’s 25th ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also known ... people who find their cholesterol levels and weight are creeping up are more likely ... don’t have any of the other symptoms. , Thyroid hormone plays a major role ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to seek ... dental implants at her Mississauga, ON practice. Dr. Williams has been providing ... of dental implants. , Missing teeth can lead to a variety of complications ...
Breaking Medicine News(10 mins):